The Effectiveness of Intervention on Insulin Injection

Status Completed

Clinical Trial Summary

The aim of the study is to assess the effectiveness of an intervention for insulin injection initiation based on the Transtheoretical Model (TTM) for insulin-naïve patients with type 2 diabetes mellitus (T2DM).

Clinical Trial Description

According to the Transtheoretical Model (TTM) proposed by Prochaska and Diclemente, people will experience different stages of change before the actual behavioral change takes place. Ineffectiveness of intervention to instigate behavioral change is largely due to failure to take into account the stage of change in which individuals are. The TTM suggests that decisional balance, which reflects the relative difference between pros and cons, is important for influencing the stage of change. In order to achieve behavioral change, the perceived pros of changing must be strengthened to outweigh the cons. In addition, individual must be self-convinced that the behavioral change is important for themselves. Furthermore, the process for behavioral change can be provided to facilitate behavioral change in individuals. The theory of TTM has yet been used to improve the behavior of insulin initiation in insulin-naïve patients with T2DM. Thus, this study aims to assess the effectiveness of an intervention for insulin injection initiation based on the TTM in insulin-naïve patients with T2DM. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03324451
Study type	Interventional
Source	Kaohsiung Medical University Chung-Ho Memorial Hospital
Contact
Status	Completed
Phase	N/A
Start date	March 1, 2018
Completion date	March 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02771093` - An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus	Phase 4
Completed	`NCT02545842` - Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)	Phase 4
Recruiting	`NCT03436212` - Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.	N/A
Completed	`NCT03244800` - A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.	Phase 2
Completed	`NCT03960424` - Diabetes Management Program for Hispanic/Latino	N/A
Withdrawn	`NCT02769091` - A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes	Phase 2
Recruiting	`NCT06065540` - A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor	Phase 3
Recruiting	`NCT05008276` - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed	`NCT04091373` - A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide	Phase 1
Completed	`NCT03296800` - Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects	Phase 1
Recruiting	`NCT06212778` - Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
Completed	`NCT05979519` - Fresh Carts for Mom's to Improve Food Security and Glucose Management	N/A
Recruiting	`NCT05579314` - XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)	Phase 1
Completed	`NCT03859934` - Metabolic Effects of Melatonin Treatment	Phase 1
Terminated	`NCT03684642` - Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin	Phase 3
Completed	`NCT03248401` - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes	Phase 4
Completed	`NCT03644134` - A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns	N/A
Completed	`NCT05295160` - Fasting-Associated Immune-metabolic Remission of Diabetes	N/A
Completed	`NCT02836873` - Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment	Phase 3
Completed	`NCT02252224` - Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance